Research Paper Volume 16, Issue 11 pp 9498—9517
THY1 is a prognostic-related biomarker via mediating immune infiltration in lung squamous cell carcinoma (LUSC)
Figure 1. Differentially expressed THY1 in a variety of cancers and normal tissues. (A) The interactive body-map revealed the median expression of THY1 in tumor (red) and normal samples (green) using GEPIA (scale: Log2 (TPM+1)). (B) The expression levels of THY1 in different tumors compared to normal tissues from ONCOMINE database. (C) The expression levels of THY1 in 33 types of cancers compared to normal tissues from TCGA in TIMER database.